Cargando…
Promoterless Gene Targeting Approach Combined to CRISPR/Cas9 Efficiently Corrects Hemophilia B Phenotype in Neonatal Mice
Many inborn errors of metabolism require life-long treatments and, in severe conditions involving the liver, organ transplantation remains the only curative treatment. Non-integrative AAV-mediated gene therapy has shown efficacy in adult patients. However, treatment in pediatric or juvenile settings...
Autores principales: | Lisjak, Michela, De Caneva, Alessia, Marais, Thibaut, Barbon, Elena, Biferi, Maria Grazia, Porro, Fabiola, Barzel, Adi, Zentilin, Lorena, Kay, Mark A., Mingozzi, Federico, Muro, Andrés F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962648/ https://www.ncbi.nlm.nih.gov/pubmed/35359664 http://dx.doi.org/10.3389/fgeed.2022.785698 |
Ejemplares similares
-
Promoterless gene targeting without nucleases rescues lethality of a Crigler‐Najjar syndrome mouse model
por: Porro, Fabiola, et al.
Publicado: (2017) -
Lethality rescue and long-term amelioration of a citrullinemia type I mouse model by neonatal gene-targeting combined to SaCRISPR-Cas9
por: Lisjak, Michela, et al.
Publicado: (2023) -
Promoterless gene targeting without nucleases ameliorates haemophilia B in mice
por: Barzel, A., et al.
Publicado: (2014) -
Optimizing CRISPR/Cas9 Editing of Repetitive Single Nucleotide Variants
por: Usher, Inga, et al.
Publicado: (2022) -
Validation Study to Determine the Accuracy of Widespread Promoterless EGFP Reporter at Assessing CRISPR/Cas9-Mediated Homology Directed Repair
por: Xu, Wanqing, et al.
Publicado: (2022)